Metcalf Donald
Walter and Eliza Hall Institute of Medical Research, Victoria, Australia.
Blood. 2008 Jan 15;111(2):485-91. doi: 10.1182/blood-2007-03-079681.
The production of hematopoietic cells is under the tight control of a group of hematopoietic cytokines. Each cytokine has multiple actions mediated by receptors whose cytoplasmic domains contain specialized regions initiating the various responses-survival, proliferation, differentiation commitment, maturation, and functional activation. Individual cytokines can be lineage specific or can regulate cells in multiple lineages, and for some cell types, such as stem cells or megakaryocyte progenitors, the simultaneous action of multiple cytokines is required for proliferative responses. The same cytokines control basal and emergency hematopoietic cell proliferation. Three cytokines, erythropoietin, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor, have now been in routine clinical use to stimulate cell production and in total have been used in the management of many millions of patients. In this little review, discussion will be restricted to those cytokines well established as influencing the production of hematopoietic cells and will exclude newer candidate regulators and those active on lymphoid cells. As requested, this account will describe the cytokines in a historical manner, using a sequential format of discovery, understanding, validation, and puzzlement, a sequence that reflects the evolving views on these cytokines over the past 50 years.
造血细胞的生成受到一组造血细胞因子的严格控制。每种细胞因子都有多种由受体介导的作用,这些受体的胞质结构域包含启动各种反应(存活、增殖、分化定向、成熟和功能激活)的特殊区域。单个细胞因子可以是谱系特异性的,也可以调节多个谱系中的细胞,对于某些细胞类型,如干细胞或巨核细胞祖细胞,增殖反应需要多种细胞因子的同时作用。相同的细胞因子控制基础和应急造血细胞增殖。三种细胞因子,即促红细胞生成素、粒细胞集落刺激因子和粒细胞-巨噬细胞集落刺激因子,现已常规用于临床以刺激细胞生成,总共已用于数百万患者的治疗。在这篇简短的综述中,讨论将限于那些已被充分证实影响造血细胞生成的细胞因子,并将排除较新的候选调节因子以及那些对淋巴细胞有活性的因子。根据要求,本报告将以历史的方式描述这些细胞因子,采用发现、理解、验证和困惑的顺序格式,该顺序反映了过去50年对这些细胞因子不断演变的观点。